Baldisseri DM, Margolis JW, Weber DJ, et al. (2002). "Olfactory marker protein (OMP) exhibits a beta-clam fold in solution: implications for target peptide interaction and olfactory signal transduction". J. Mol. Biol. 319 (3): 823–837. doi:10.1016/S0022-2836(02)00282-6. PMID12054873.
Alvarez E, Zhou W, Witta SE, Freed CR (2005). "Characterization of the Bex gene family in humans, mice, and rats". Gene. 357 (1): 18–28. doi:10.1016/j.gene.2005.05.012. PMID15958283.
Foltz G, Ryu GY, Yoon JG, et al. (2006). "Genome-wide analysis of epigenetic silencing identifies BEX1 and BEX2 as candidate tumor suppressor genes in malignant glioma". Cancer Res. 66 (13): 6665–6674. doi:10.1158/0008-5472.CAN-05-4453. PMID16818640.
Fischer C, Drexler HG, Reinhardt J, et al. (2007). "Epigenetic regulation of brain expressed X-linked-2, a marker for acute myeloid leukemia with mixed lineage leukemia rearrangements". Leukemia. 21 (2): 374–377. doi:10.1038/sj.leu.2404493. PMID17251904.
Naderi A, Teschendorff AE, Beigel J, et al. (2007). "BEX2 is overexpressed in a subset of primary breast cancers and mediates nerve growth factor/nuclear factor-kappaB inhibition of apoptosis in breast cancer cell lines". Cancer Res. 67 (14): 6725–6736. doi:10.1158/0008-5472.CAN-06-4394. PMID17638883.